HUMANIZED AND VARIANT TGF-β3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF Application WO-2020095104-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
HUMANIZED AND VARIANT TGF-BETA1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF Application WO-2020095113-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
TGF-β3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF Application WO-2016201282-A2 World Intellectual Property Organisation (WIPO) 15 Dec 2016
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent Application EP-2248895-A2 European Patent Office 10 Nov 2010
Cripto antagonism of activin and TGF-b signaling Grant US-7820620-B2 United States of America 26 Oct 2010
METHODS TO TREAT OR PREVENT VIRAL-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS Application EP-1809324-A4 European Patent Office 25 Feb 2009
METHODS TO TREAT OR PREVENT VIRAL-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS Application EP-1809324-A2 European Patent Office 25 Jul 2007